Centessa Pharmaceuticals plc (LON:0ACX)
London · Delayed Price · Currency is GBP · Price in USD 23.60
+0.40 (1.73%)
At close: Feb 12, 2026
Centessa Pharmaceuticals Employees
Centessa Pharmaceuticals had 114 employees as of September 30, 2025. The number of employees increased by 39 or 52.00% compared to the same quarter last year.
Employees
114
Change
39
Growth
52.00%
Revenue / Employee
97.89K GBP
Profits / Employee
-1.58M GBP
Market Cap
2.52B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 114 | 39 | 52.00% |
| Jun 30, 2025 | 98 | 26 | 36.11% |
| Mar 31, 2025 | 86 | 9 | 11.69% |
| Dec 31, 2024 | 77 | 1 | 1.32% |
| Sep 30, 2024 | 75 | 0 | - |
| Jun 30, 2024 | 72 | 8 | 12.50% |
| Mar 31, 2024 | 77 | -5 | -6.10% |
| Dec 31, 2023 | 76 | -7 | -8.43% |
| Sep 30, 2023 | 75 | 7 | 10.29% |
| Jun 30, 2023 | 64 | -4 | -5.88% |
| Mar 31, 2023 | 82 | -8 | -8.89% |
| Dec 31, 2022 | 83 | -7 | -7.78% |
| Sep 30, 2022 | 68 | -2 | -2.86% |
| Jun 30, 2022 | 68 | 23 | 51.11% |
| Mar 31, 2022 | 90 | 45 | 100.00% |
| Dec 31, 2021 | 90 | - | - |
| Sep 30, 2021 | 70 | - | - |
| Jun 30, 2021 | 45 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| TBC Bank Group | 12,900 |
| International Workplace Group | 10,000 |
| QinetiQ Group | 8,000 |
| Morgan Sindall Group | 8,000 |
| Vistry Group | 4,587 |
| Pennon Group | 3,600 |
| Quilter | 3,017 |
| Shawbrook Group | 1,566 |
Centessa Pharmaceuticals News
- 15 hours ago - Nxera Pharma to Receive $1.8 Million Milestone Payment from Centessa Pharmaceuticals - GlobeNewsWire
- 22 hours ago - FMR LLC's Strategic Acquisition of Centessa Pharmaceuticals Shares - GuruFocus
- 6 days ago - First Week of CNTA January 2027 Options Trading - Nasdaq
- 9 days ago - Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 10 days ago - This Fund Locked In Gains With a $14.5 Million Biotech Exit Amid a Staggering Stock Rally - The Motley Fool
- 14 days ago - Truist Securities Raises Price Target on CNTA to $38, Maintains Buy Rating | CNTA Stock News - GuruFocus
- 27 days ago - First Week of CNTA March 20th Options Trading - Nasdaq
- 4 weeks ago - Centessa Pharmaceuticals Announces Poster Presentation of New Preclinical Data Supporting Expansion of Orexin Receptor 2 (OX2R) Agonist Pipeline into Neuropsychiatric Indications at the 64th ACNP Annual Meeting - GlobeNewsWire